Engineers Gate Manager’s Genmab GMAB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-29,301
Closed -$902K 2315
2025
Q4
$902K Buy
29,301
+15,909
+119% +$496K 0.01% 1088
2025
Q3
$411K Sell
13,392
-64,759
-83% -$1.58M ﹤0.01% 1604
2025
Q2
$1.61M Sell
78,151
-11,216
-13% -$230K 0.02% 851
2025
Q1
$1.75M Buy
89,367
+29,370
+49% +$616K 0.03% 751
2024
Q4
$1.25M Buy
59,997
+43,840
+271% +$963K 0.02% 867
2024
Q3
$394K Sell
16,157
-858
-5% -$22.9K 0.01% 1497
2024
Q2
$428K Buy
+17,015
New +$482K 0.01% 1290
2024
Q1
Sell
-27,260
Closed -$868K 2057
2023
Q4
$868K Buy
+27,260
New +$856K 0.02% 872
2023
Q3
Sell
-11,617
Closed -$442K 1907
2023
Q2
$442K Buy
+11,617
New +$463K 0.02% 1106
2023
Q1
Sell
-16,894
Closed -$716K 1791
2022
Q4
$716K Buy
+16,894
New +$696K 0.04% 689

Other funds holding GMAB

Engineers Gate Manager's GMAB Position: Q1 2026 in Review

Engineers Gate Manager sold out of Genmab (GMAB) in Q1 2026, closing a stake of 29,301 shares — an estimated $902K sold.

Engineers Gate Manager first reported a position in GMAB in Q4 2022 and held it in 10 quarters. The position peaked at $1.75M in Q1 2025. 272 funds tracked by Wall St. Rank hold GMAB as of Q1 2026.

  • Engineers Gate Manager reported no remaining Genmab position as of Q1 2026 after selling out during the quarter.
  • Engineers Gate Manager sold 29,301 Genmab shares in Q1 2026, an estimated $902K.
  • Engineers Gate Manager first reported a position in Genmab in Q4 2022 and held it in 10 quarters.
  • Engineers Gate Manager's Genmab position peaked at $1.75M in Q1 2025.
  • 272 funds tracked by Wall St. Rank held Genmab as of Q1 2026.

Based on Engineers Gate Manager's 13F filing for Q1 2026, filed 15 May 2026.